NEW YORK (GenomeWeb) – Dow AgroSciences and Critical Path Services today announced a license agreement for patents related to plant proteomics.

Under the terms of the agreement, Critical Path will receive a non-exclusive license to intellectual property held by Dow AgroSciences, a wholly-owned subsidiary of Dow Chemical, including Plextein, a high-throughput method for multiplex detection of proteins in plants using liquid chromatography with tandem mass spectroscopy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.